From Service to Skilled Trades The Untapped Pipeline Reshaping Americas Labor Market Rise in Solar Panel Sales Driven by Energy Cost Concerns Options Trading Without BlackScholes Model Chart Reading Gains Prominence SpaceX and OpenAI IPOs Could Surpass Berkshire Hathaways Market Cap on Debut Day Lam Research Corporation Rallies on Strong AIDriven Semiconductor Equipment Demand The Federal Reserve Faces Diminishing Rationale for Interest Rate Cuts Amid Stubborn Cost Pressures BWLP Q4 2025 Earnings EPS Beats Estimates Stock Slips on Market Sentiment COSM Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges Franklin Resources BEN Q1 2026 Earnings Strong Earnings Beat Overshadows Revenue Uncertainty GOCO Q1 2026 Earnings EPS Misses Estimates as Losses Widen Latham Group SWIM Q1 2026 Earnings EPS Surprise Drives Shares Higher CHTR Q1 2026 Earnings EPS Misses Estimates as Broadband Subscriber Trends Pressure Results Bold Eagle Acquisition Corp BEAG Holds Steady at 1058 as SPAC Consolidates Gorilla Technology Warrant GRRRW Retreats Toward Support Amid Thin Trading InfuSystems INFU Pulls Back 282 as Shares Test Key Support Near 918 InMode INMD Pushes Higher Testing Resistance After a 16 Gain Kinross Gold KGC Steps Back from Resistance Support Levels in Focus Genpact CEO Suggests AI Could Reduce IT Workload and Slow Job Growth MDGL Q1 2026 Earnings NarrowerthanExpected Loss as Rezdiffra Launch Progresses First Citizens BancShares Preferred Series C FCNCO Steady at 212 as Yield Seekers Weigh Stability Equity Residential EQR Q1 2026 Earnings EPS Miss Highlights Sector Headwinds Yet Stock Edges Higher VUZI Q1 2026 Earnings EPS Surprises Positively Amid Ongoing Challenges Diamondrock Hospitality DRH Q1 2026 Earnings EPS Surges Past Estimates Despite Undisclosed Revenue FNF Q1 2026 Earnings EPS Falls 1095 Below Estimates as Housing Headwinds Persist FNLC Q1 2026 Earnings EPS of 080 Reported Amid Quiet Quarter ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Controlled Spending Amid Clinical Progress Sagimet Biosciences Inc Q1 2026 Earnings Narrowed Loss Beats Expectations as Clinical Pipeline Advances